A Study to Evaluate Endometriosis with PET/MRI

Overview

About this study

The purpose of this study is to demonstrate the feasibility of F18- FES PET/MRI in patients with endometriosis, to establish the normal bio-distribution of F18- FES in pre-menopausal women, and to compare the diagnostic performance of F18- FES PET/MRI with that of conventional imaging (ultrasound and MRI alone) using surgical findings as the reference standard.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Premenopausal women (18-50 years old).
  • Subjects with endometriosis.

Exclusion Criteria: 

  • Postmenopausal women.
  • AP diameter when lying supine greater than 32 cm 
  • Unable to undergo PET/MRI for any reason (metal implants, severe claustrophobia)
  • Unable to receive IV Gadolinium contrast for any reason (renal failure eGFR < 60, contrast allergy)
  • Pregnant 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Ann Bender, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20475883

Mayo Clinic Footer